GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,002,000 | -12.0% | 44,084 | -58.7% | 0.06% | -39.4% |
| Q2 2022 | $3,412,000 | +47.9% | 106,796 | +60.4% | 0.09% | +51.6% |
| Q1 2022 | $2,307,000 | +1019.9% | 66,599 | +1298.6% | 0.06% | +342.9% |
| Q4 2020 | $206,000 | -88.1% | 4,762 | -78.2% | 0.01% | -87.6% |
| Q4 2019 | $1,733,000 | -74.9% | 21,800 | -84.7% | 0.11% | -72.5% |
| Q3 2019 | $6,895,000 | +340.0% | 142,100 | +376.8% | 0.41% | +139.0% |
| Q2 2019 | $1,567,000 | -9.7% | 29,800 | -9.1% | 0.17% | -39.9% |
| Q1 2019 | $1,736,000 | – | 32,800 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |